X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Intellectual property is the key to vaccine development, manufacturing and technology sharing

By Megan Van Etten  |    March 5, 2021
Earlier today, 31 PhRMA board members signed a letter to President Joe Biden applauding the Administration’s accelerating COVID-19 vaccine rollout, but also warning against efforts to undermine...   Read More

How industry collaboration and partnerships are supporting COVID-19 vaccine manufacturing

By Richard Moscicki, M.D.  |    March 4, 2021
Across the industry, biopharmaceutical companies are working around the clock to meet the demands of COVID-19 vaccine manufacturing. Companies are working to source needed raw materials and other...   Read More

American biopharmaceutical manufacturing: Fueling economic growth now and for years to come

By Nicole Longo  |    December 21, 2020
As the world has grappled with the current pandemic, there has been increased focus on biopharmaceutical manufacturing and its global supply chain. Many wondered whether the biopharmaceutical...   Read More

Manufacturing Day 2020: A closer look at the biopharmaceutical industry’s contributions

By Megan Van Etten  |    October 2, 2020
The first Friday of October marks Manufacturing Day, an annual recognition of the critical role manufacturing industries play in powering innovation and generating jobs and economic growth for...   Read More

Guest Post: How proactivity and planning helped Novartis ensure a stable supply of medicines during COVID-19

By Guest Contributor  |    September 16, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

By the numbers: A look at the sourcing of API used in medicines consumed in the United States

By Nicole Longo  |    July 16, 2020
There has been a lot of focus of late on where active pharmaceutical ingredients (APIs) for medicines are manufactured. While some may claim we are reliant on other countries, putting us at risk...   Read More

Stakeholders raise concerns with proposed drastic changes to the pharmaceutical supply chain

By Nicole Longo  |    June 11, 2020
As we work to combat the current global pandemic, it is especially critical to maintain the stability of our global manufacturing supply chain. Unfortunately, recent policy proposals that would...   Read More

America’s global leadership in biopharmaceutical manufacturing

By Nicole Longo  |    June 4, 2020
Unfortunately, there are a lot of assertions floating around that tell a misleading story about pharmaceutical manufacturing, diminishing America’s leadership and suggesting our reliance on other...   Read More

It’s a good thing pharmaceutical manufacturing supply chains are spread out around the world

By Nicole Longo  |    May 21, 2020
The biopharmaceutical industry is committed to ensuring Americans and people around the world have access to the medicines they need. As a result, companies do everything they can to make sure...   Read More

Setting up a pharmaceutical manufacturing supply chain is a complex and lengthy process

By Nicole Longo  |    May 14, 2020
Did you know that biopharmaceutical manufacturers must begin setting up the manufacturing supply chain for a medicine years before that medicine is even approved for use by patients? That’s a fact...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates